)
Shanghai Pharmaceuticals (601607) investor relations material
Shanghai Pharmaceuticals Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved stable growth with revenue of RMB 75.26 billion, up 6.36% year-over-year for Q1 2026.
Net profit attributable to shareholders reached RMB 1.42 billion, up 6.35% year-over-year.
Industrial segment sales grew 15.64% and commercial segment sales rose 5.52% year-over-year.
R&D investment was RMB 577 million, 8.47% of industrial sales.
Financial highlights
Operating income: RMB 75.26 billion, up 6.36% year-over-year.
Net profit attributable to shareholders: RMB 1.42 billion, up 6.35% year-over-year.
Adjusted net profit (excluding non-recurring items): RMB 1.24 billion, down 2.02% year-over-year.
Basic and diluted EPS: RMB 0.3823, up 6.35% year-over-year.
Operating cash flow: -RMB 1.01 billion, improved from -RMB 2.20 billion year-over-year.
Outlook and guidance
Continued focus on new drug R&D and commercialization.
Ongoing digital transformation and integration of new retail strategies.
- Net profit surged 25.74% on one-time gains, while adjusted profit declined 5.56% year-over-year.601607
H2 202531 Mar 2026 - H1 2024 revenue up 5.14%, net profit up 12.72%, interim dividend proposed.601607
H1 202419 Dec 2025 - Net profit surged 20.82% on 5.75% revenue growth, with strong cash flow and R&D investment.601607
H2 202419 Dec 2025 - Net profit surged 51.56% on a 1.56% revenue increase, driven by a one-time consolidation gain.601607
H1 202519 Dec 2025 - Q3 profit dropped 38% on higher impairments, but YTD revenue and net profit rose on one-time gains.601607
Q3 202531 Oct 2025 - Revenue up slightly, but net profit declined amid cost pressures; innovation segments strong.601607
Q1 202510 Sep 2025 - Revenue and net profit rose, driven by commercial and CSO sales despite industrial decline.601607
Q3 202413 Jun 2025
Next Shanghai Pharmaceuticals earnings date
Next Shanghai Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)